Tourmaline Bio, Inc. (TRML)
(Delayed Data from NSDQ)
$26.30 USD
+0.78 (3.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $26.28 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.84 |
EPS Last Quarter | -0.68 |
Last EPS Surprise | 5.56% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.08 |
Next Year | -3.52 |
EPS (TTM) | -3.68 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 60.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 60.00M |
Low Estimate | NA | NA | NA | 60.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.84 | -0.91 | -3.08 | -3.52 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.75 | -0.80 | -2.85 | -3.39 |
High Estimate | -0.75 | -0.80 | -2.79 | -1.68 |
Low Estimate | -0.97 | -1.23 | -3.75 | -4.60 |
Year ago EPS | -1.64 | -0.81 | -8.87 | -3.08 |
Year over Year Growth Est. | 48.78% | -12.35% | 65.28% | -14.45% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.84 | -0.91 | -3.08 | -3.52 |
7 Days Ago | -0.84 | -0.91 | -3.08 | -3.52 |
30 Days Ago | -0.84 | -0.91 | -3.12 | -3.52 |
60 Days Ago | -0.84 | -0.91 | -3.12 | -3.52 |
90 Days Ago | -0.76 | -0.83 | -2.94 | -3.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.84 | -0.91 | -2.85 | -3.52 |
Zacks Consensus Estimate | -0.84 | -0.91 | -3.08 | -3.52 |
Earnings ESP | 0.00% | 0.00% | 7.32% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.68 | -0.55 | -0.81 | -1.64 | NA |
Estimate | -0.72 | -0.68 | -0.75 | -0.94 | NA |
Difference | 0.04 | 0.13 | -0.06 | -0.70 | -0.15 |
Surprise | 5.56% | 19.12% | -8.00% | -74.47% | -14.45% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more